First mRNA Vaccine Against Antibiotic-Resistant Bacteria Developed

Researchers from Tel Aviv University and the Israel Institute for Biological Research have leveraged COVID-19 vaccine technology to create the world's first mRNA-based vaccine against a deadly, antibiotic-resistant bacterium. The vaccine, targeting *Yersinia pestis* (the cause of bubonic plague), demonstrated 100% protection against pneumonic plague in animal models. This groundbreaking technology holds promise for combating other lethal bacteria, offering a new hope in global public health. The study is featured in *Advanced Science*.